Pangenomic Health Inc
CNSX:NARA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pangenomic Health Inc
CNSX:NARA
|
CA |
|
RevoluGROUP Canada Inc
XTSX:REVO
|
CA |
|
Hisense Home Appliances Group Co Ltd
SZSE:000921
|
CN |
|
Alimera Sciences Inc
NASDAQ:ALIM
|
US |
|
S
|
SRIVARU Holding Ltd
NASDAQ:SVMH
|
KY |
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
CN |
|
V
|
Vinci SA
OTC:VCISY
|
FR |
|
Synergy Group Holdings International Ltd
HKEX:1539
|
HK |
|
Gryphon Digital Mining Inc
NASDAQ:ABTC
|
US |
|
M
|
Megaworld Corp
XPHS:MEG
|
PH |
Cash Flow Statement
Cash Flow Statement
Pangenomic Health Inc
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
(4)
|
(5)
|
(12)
|
(12)
|
(12)
|
(12)
|
(3)
|
(2)
|
(4)
|
(4)
|
(4)
|
(4)
|
(2)
|
(3)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Non-Cash Items |
2
|
2
|
9
|
9
|
9
|
9
|
0
|
0
|
2
|
2
|
2
|
3
|
0
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
(0)
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(3)
-42%
|
(3)
+13%
|
(3)
-5%
|
(3)
+7%
|
(2)
+41%
|
(2)
+1%
|
(1)
+49%
|
(0)
+38%
|
(0)
+26%
|
(0)
+84%
|
(0)
-101%
|
(0)
-85%
|
(2)
-683%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+98%
|
(0)
-378%
|
(0)
-3%
|
(0)
+4%
|
(0)
+5%
|
(0)
+94%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
4
|
1
|
1
|
2
|
1
|
1
|
1
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
2
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
4
N/A
|
1
-72%
|
2
+37%
|
2
+43%
|
1
-34%
|
2
+8%
|
1
-8%
|
1
-45%
|
1
-37%
|
0
-25%
|
0
-88%
|
0
+94%
|
0
+129%
|
2
+695%
|
|
| Change in Cash | |||||||||||||||
| Net Change in Cash |
1
N/A
|
(2)
N/A
|
(1)
+39%
|
(1)
+43%
|
(1)
-76%
|
(0)
+99%
|
(0)
-387%
|
0
N/A
|
0
+19%
|
0
+20%
|
(0)
N/A
|
(0)
-127%
|
(0)
+71%
|
0
N/A
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(2)
N/A
|
(3)
-42%
|
(3)
+13%
|
(3)
-5%
|
(3)
+7%
|
(2)
+41%
|
(2)
+1%
|
(1)
+49%
|
(0)
+38%
|
(0)
+26%
|
(0)
+84%
|
(0)
-101%
|
(0)
-85%
|
(2)
-683%
|
|